Recovery from Severe Myelosuppression

Management Priorities

• The National Comprehensive Cancer Network recommends holding chemotherapy until adequate recovery: ANC ≥1000-1500/mm³, platelets ≥50,000-100,000/mm³, and hemoglobin adequate 1
• Consideration of G-CSF for future cycles to reduce neutropenia duration is suggested, as growth factors are standard with myelosuppressive platinum-based regimens 2
• Consideration of G-CSF for future cycles to reduce neutropenia duration is also supported by another guideline from the National Comprehensive Cancer Network 3